Evidence map›Paper›PMID 21553170›Full record

ArticleClinical orthopaedics and related research2011

Evaluation of two sources of calcium sulfate for a local drug delivery system: a pilot study.

Ashley C Parker, J Keaton Smith, Harry S Courtney, Warren O Haggard

Abstract readEvaluation Study
In one paragraph

Article in Clinical orthopaedics and related research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identifying alternative antibiotics that elute from calcium sulfate beads for treatment of orthopedic infections.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Influence of third-body particles originating from bone void fillers on the wear of ultra-high-molecular-weight polyethylene.Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine · 2016
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ashley C ParkerDepartment of Biomedical Engineering, University of Memphis, 321H Engineering Technology Building, Memphis, TN 38152, USA. alcox3@memphis.edu
J Keaton Smith
Harry S Courtney
Warren O Haggard
University of Memphis · USUniversity of Tennessee Health Science Center · US

Funding

NIAID NIH HHS R01 AI06907-02
6 · The paper itself

Abstract

backgroundLocal drug delivery has substantial potential to prevent infections compared with systemic delivery. Although calcium sulfate (CaSO(4)) has been studied for local drug delivery and two types are commercially available, it is unknown whether they differentially release antibiotics. QUESTIONS/PURPOSES: We determined the differences between two sources of CaSO(4) and the K(2)SO(4) catalyst's presence on the degradation, daptomycin elution, and activity against Staphylococcus aureus.

methodsWe formed pellets from synthetic and naturally sourced (from gypsum) CaSO(4) and loaded with 5% daptomycin and 3% or 0% K(2)SO(4). We used in vitro experiments to determine the daptomycin concentration and degradation profiles over 10 days. Turbidity assays were used to evaluate the activity of the daptomycin eluates against S. aureus.

resultsAll pellets exhibited a bolus release with the highest daptomycin concentration on Day 1 with the sourced CaSO(4) pellets. The synthetic CaSO(4) pellets with 3% K(2)SO(4) exhibited a slower drug release compared with the synthetic CaSO(4) pellets with 0% K(2)SO(4), which degraded and eluted daptomycin too quickly to inhibit S. aureus. Turbidity assays demonstrated that all CaSO(4) pellets inhibit S. aureus for expected lengths of time.

conclusionsOur preliminary in vitro data suggest differences in the degradation, elution, and activity properties between sourced and synthetic CaSO(4) pellets. The addition of K(2)SO(4) appeared beneficial when using synthetic CaSO(4). Synthetic CaSO(4) may be effective when slow degradation and longer elution times are needed. CLINICAL RELEVANCE: Local delivery of eluted daptomycin can be tailored through material selection and K(2)SO(4) addition.

Indexed as

Anti-Bacterial AgentsCalcium SulfateDaptomycinDrug Delivery SystemsKineticsMicrobial Sensitivity TestsPilot ProjectsStaphylococcus aureusSulfatesAnti-Bacterial AgentsCalcium SulfateDaptomycinpotassium sulfateSulfates

Identifiers

PMID21553170
PMCPMC3183187
OpenAlexW1968989438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.